MyD88-mediated signaling prevents development of adenocarcinomas of the colon: role of interleukin 18
Open accessThe DOI matches its Crossref record; 42 of the 44 references it cites were found in a registry or an index.
Abstract
Signaling through the adaptor protein myeloid differentiation factor 88 (MyD88) promotes carcinogenesis in several cancer models. In contrast, MyD88 signaling has a protective role in the development of azoxymethane (AOM)/dextran sodium sulfate (DSS) colitis-associated cancer (CAC). The inability of Myd88(-/-) mice to heal ulcers generated upon injury creates an altered inflammatory environment that induces early alterations in expression of genes encoding proinflammatory factors, as well as pathways regulating cell proliferation, apoptosis, and DNA repair, resulting in a dramatic increase in adenoma formation and progression to infiltrating adenocarcinomas with frequent clonal mutations in the beta-catenin gene. Others have reported that toll-like receptor (Tlr) 4-deficient mice have a similar susceptibility to colitis to Myd88-deficient mice but, unlike the latter, are resistant to CAC. We have observed that mice deficient for Tlr2 or Il1r do not show a differential susceptibility to colitis or CAC. However, upon AOM/DSS treatment Il18(-/-) and Il18r1(-/-) mice were more susceptible to colitis and polyp formation than wild-type mice, suggesting that the phenotype of Myd88(-/-) mice is, in part, a result of their inability to signal through the IL-18 receptor. This study revealed a previously unknown level of complexity surrounding MyD88 activities downstream of different receptors that impact tissue homeostasis and carcinogenesis.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures







Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“In fact, IL-18 KO or IL-18R KO mice are also highly sensitive to colitis-associated CRC [124,125].”
From Gut Microbiota and Cancer: From Pathogenesis to Therapy (2019) · cites this paper as [125]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Cluster analysis and display of genome-wide expression patterns
Eisen, M. B., Spellman, P. T., Brown, P. O., & Botstein, D. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.25.14863 · Cited by 16,184
STATs in cancer inflammation and immunity: a leading role for STAT3
Yu, H., Pardoll, D., & Jove, R. (2009) · Nature reviews. Cancer · doi:10.1038/nrc2734 · Cited by 4,383 · cited 4×
“We observed enhanced expression of several known STAT3-dependent genes (Yu et al., 2009) in addition to Il6 and Il11 in AOM/DSS-treated Myd88/ mice, including Cox2, Hif1a, and several metalloproteases.”
BackgroundInfluentialRecognition of Commensal Microflora by Toll-Like Receptors Is Required for Intestinal Homeostasis
Rakoff-Nahoum, S., Paglino, J., Eslami-Varzaneh, F., Edberg, S., & Medzhitov, R. (2004) · Cell · doi:10.1016/j.cell.2004.07.002 · Cited by 4,251 · cited 2×
“RESULTS Myd88/ mice show increased susceptibility to develop colonic tumors after AOM/DSS administration Myd88/ mice are highly susceptible to the development of colitis induced by irradiation or DSS as a result of reduced ability to repair the mucosal integrity after injury with significant morbidity and mortalit…”
BackgroundIKKβ Links Inflammation and Tumorigenesis in a Mouse Model of Colitis-Associated Cancer
Greten, F. R., Eckmann, L., Greten, T. F., Park, J. M., Li, Z.-W., Egan, L. J., Kagnoff, M. F., & Karin, M. (2004) · Cell · doi:10.1016/j.cell.2004.07.013 · Cited by 2,433
Grivennikov, S., Karin, E., Terzic, J., Mucida, D., Yu, G.-Y., Vallabhapurapu, S., Scheller, J., Rose-John, S., Cheroutre, H., Eckmann, L., et al. (2009) · Cancer Cell · doi:10.1016/j.ccr.2009.01.001 · Cited by 2,155 · cited 2×
“STAT3 activation in both epithelial cells and in stromal and infiltrating cells has been shown to regulate the tumor inflammatory environment as well as to have direct effects on the tumor itself by inducing antiapoptotic, proangiogenic, and proproliferative gene expression programs (Grivennikov et al., 2009; Yu et al…”
BackgroundSystematic variation in gene expression patterns in human cancer cell lines
Ross, D. T., Scherf, U., Eisen, M. B., Perou, C. M., Rees, C., Spellman, P., Iyer, V., Jeffrey, S. S., Van de Rijn, M., Waltham, M., et al. (2000) · Nature Genetics · doi:10.1038/73432 · Cited by 2,088
Gender Disparity in Liver Cancer Due to Sex Differences in MyD88-Dependent IL-6 Production
Naugler, W. E., Sakurai, T., Kim, S., Maeda, S., Kim, K., Elsharkawy, A. M., & Karin, M. (2007) · Science · doi:10.1126/science.1140485 · Cited by 1,955
Landon, M., Saam, J., Brown, K. L., Moyes, K., Evans, B., & Wenstrup, R. (2015) · Oncology · doi:10.1159/000430097 · Cited by 1,939
Interferons, immunity and cancer immunoediting
Dunn, G. P., Koebel, C. M., & Schreiber, R. D. (2006) · Nature Reviews Immunology · doi:10.1038/nri1961 · Cited by 1,617 · cited 2×
“…and Il18/ mice to colon carcinogenesis might exclusively be the result of the lack of an immunosurveillance effect of adaptive immunity and IFN- (Dunn et al., 2006), particularly when it is considered that Rag/ immunodeficient mice have reduced rather than increased susceptibility to colon…”
BackgroundStabilization of β-Catenin by Genetic Defects in Melanoma Cell Lines
Rubinfeld, B., Robbins, P., El-Gamil, M., Albert, I., Porfiri, E., & Polakis, P. (1997) · Science · doi:10.1126/science.275.5307.1790 · Cited by 1,223
Cited by
Role of the microbiota in immunity and inflammation.
Belkaid, Y., & Hand, T. W. (2014) · Cell · doi:10.1016/j.cell.2014.03.011 · Cited by 5,385
Intestinal epithelial cells: regulators of barrier function and immune homeostasis
Peterson, L. W., & Artis, D. (2014) · Nature Reviews Immunology · doi:10.1038/nri3608 · Cited by 3,173
Singh, N., Gurav, A., Sivaprakasam, S., Brady, E., Padia, R., Shi, H., Thangaraju, M., Prasad, P. D., Manicassamy, S., Munn, D. H., et al. (2014) · Immunity · doi:10.1016/j.immuni.2013.12.007 · Cited by 2,368
Pyroptosis: Mechanisms and Diseases
Yu, P., Zhang, X., Liu, N., Tang, L., Peng, C., & Chen, X. (2021) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-021-00507-5 · Cited by 2,353
Natural Innate and Adaptive Immunity to Cancer
Vesely, M. D., Kershaw, M. H., Schreiber, R. D., & Smyth, M. J. (2011) · Annual Review of Immunology · doi:10.1146/annurev-immunol-031210-101324 · Cited by 2,101
Inflammation-induced cancer: Crosstalk between tumours, immune cells and microorganisms
Elinav, E., Nowarski, R., Thaiss, C. A., Hu, B., Jin, C., & Flavell, R. A. (2013) · Nature reviews. Cancer · doi:10.1038/nrc3611 · Cited by 2,000
Intestinal homeostasis and its breakdown in inflammatory bowel disease
Maloy, K. J., & Powrie, F. (2011) · Nature · doi:10.1038/nature10208 · Cited by 1,870
Schwabe, R. F., & Jobin, C. (2013) · Nature Reviews Cancer · doi:10.1038/nrc3610 · Cited by 1,689
The Inflammasome NLRs in Immunity, Inflammation, and Associated Diseases
Davis, B. K., Wen, H., & Ting, J. P.-Y. (2011) · Annual Review of Immunology · doi:10.1146/annurev-immunol-031210-101405 · Cited by 1,618
STING: infection, inflammation and cancer.
Barber, G. N. (2015) · Nature Reviews Immunology · doi:10.1038/nri3921 · Cited by 1,313
Inflammasomes and Their Roles in Health and Disease
Lamkanfi, M., & Dixit, V. M. (2012) · Annual Review of Cell and Developmental Biology · doi:10.1146/annurev-cellbio-101011-155745 · Cited by 935
“…in protection against colon inflammation was confirmed in mice lacking ASC and caspase-1 (Allen et al. 2010, Dupaul-Chicoine et al. 2010, Zaki et al. 2010a) as well as in animals lacking IL-1β and IL-18 or their cognate receptors (Lebeis et al. 2009, Salcedo et al. 2010, Takagi et al. 2003).”
BackgroundMicrobiota: a key orchestrator of cancer therapy
Roy, S., & Trinchieri, G. (2017) · Nature Reviews Cancer · doi:10.1038/nrc.2017.13 · Cited by 883
Self-citationMechanisms and consequences of intestinal dysbiosis
Weiss, G. A., & Hennet, T. (2017) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-017-2509-x · Cited by 775
“By contrast, mice with chemically induced colitis had more intestinal tumors without MyD88 signaling [210].”
BackgroundIL-22BP is regulated by the inflammasome and modulates tumorigenesis in the intestine
Huber, S., Gagliani, N., Zenewicz, L. A., Huber, F. J., Bosurgi, L., Hu, B., Hedl, M., Zhang, W., O’Connor, W., Murphy, A. J., et al. (2012) · Nature · doi:10.1038/nature11535 · Cited by 719
“Recent publications have shown that Il18 −/− mice have increased inflammation and tumor development in the colitis associated colon cancer model 26, 27 .”
Experimental Models of Inflammatory Bowel Diseases
Kiesler, P., Fuss, I. J., & Strober, W. (2015) · Cellular and Molecular Gastroenterology and Hepatology · doi:10.1016/j.jcmgh.2015.01.006 · Cited by 713
Diverging inflammasome signals in tumorigenesis and potential targeting
Karki, R., & Kanneganti, T.-D. (2019) · Nature Reviews Cancer · doi:10.1038/s41568-019-0123-y · Cited by 641
Inflammasomes in carcinogenesis and anticancer immune responses
Zitvogel, L., Kepp, O., Galluzzi, L., & Kroemer, G. (2012) · Nature Immunology · doi:10.1038/ni.2224 · Cited by 593
“Mice that lack the inflammasome substrates Il-1β and Il-18 or their cognate receptors are more susceptible to chemically induced colitis than are their wild-type littermate”
BackgroundXia, T., Konno, H., Ahn, J., & Barber, G. N. (2016) · Cell Reports · doi:10.1016/j.celrep.2015.12.029 · Cited by 589
“A uthor M anuscript A uthor M anuscript A uthor M anuscript A uthor M anuscript (Barker et al., 2011; Elinav et al., 2013; Huber et al., 2012; Salcedo et al., 2010).”
BackgroundGut Microbiota and Cancer: From Pathogenesis to Therapy
Vivarelli, S., Salemi, R., Candido, S., Falzone, L., Santagati, M., Stefani, S., Torino, F., Banna, G. L., Tonini, G., & Libra, M. (2019) · Cancers · doi:10.3390/cancers11010038 · Cited by 586
“Further studies are needed to assess whether inflammasomes and/or IL-18 inhibit CRC development in genetic CRC models (such as the APC/min mice), as well as in human CRC. Relevantly, Lactobacilli are able to activate the inflammasomes in human primary macrophages, as well as in primary mammalian gut epithelial cells,…”
BackgroundInfluentialEpithelial IL-18 Equilibrium Controls Barrier Function in Colitis
Nowarski, R., Jackson, R., Gagliani, N., de Zoete, M. R., Palm, N. W., Bailis, W., Low, J. S., Harman, C. C. D., Graham, M., Elinav, E., et al. (2015) · Cell · doi:10.1016/j.cell.2015.10.072 · Cited by 558
“The use of IL-18- and IL-18R1-deficient mice identified IL-18 as a putative host molecule required to protect intestinal epithelial cells from intestinal inflammation and colitis (Salcedo et al., 2010).”
Inflammation and colorectal cancer: colitis-associated neoplasia
Grivennikov, S. I. (2013) · Seminars in Immunopathology · doi:10.1007/s00281-012-0352-6 · Cited by 551
Inflammatory cytokines in cancer: tumour necrosis factor and interleukin 6 take the stage
Grivennikov, S. I., & Karin, M. (2011) · Annals of the Rheumatic Diseases · doi:10.1136/ard.2010.140145 · Cited by 560
Allen, I. C., Wilson, J. E., Schneider, M., Lich, J. D., Roberts, R. A., Arthur, J. C., Woodford, R.-M. T., Davis, B. K., Uronis, J. M., Herfarth, H. H., et al. (2012) · Immunity · doi:10.1016/j.immuni.2012.03.012 · Cited by 534
NF-κB in the regulation of epithelial homeostasis and inflammation
Wullaert, A., Bonnet, M. C., & Pasparakis, M. (2011) · Cell Research · doi:10.1038/cr.2010.175 · Cited by 521
Cancer and Inflammation: An Old Intuition with Rapidly Evolving New Concepts
Trinchieri, G. (2012) · Annual Review of Immunology · doi:10.1146/annurev-immunol-020711-075008 · Cited by 511
Self-citationThe host STING pathway at the interface of cancer and immunity
Corrales, L., McWhirter, S. M., Dubensky, T. W., & Gajewski, T. F. (2016) · Journal of Clinical Investigation · doi:10.1172/jci86892 · Cited by 487
“Mechanistically, AOM induced DNA damage and triggered STING signaling that activated inflammatory wound repair–initiating cytokines, such as IL-1β and IL-18, and suppressed growth inhibitory IL-22 binding protein (IL-22BP) (57, 59, 60).”
BackgroundIljazovic, A., Roy, U., Gálvez, E. J. C., Lesker, T. R., Zhao, B., Gronow, A., Amend, L., Will, S. E., Hofmann, J. D., Pils, M. C., et al. (2021) · Mucosal Immunology · doi:10.1038/s41385-020-0296-4 · Cited by 454
Inflammation-induced tumorigenesis in the colon is regulated by caspase-1 and NLRC4
Hu, B., Elinav, E., Huber, S., Booth, C. J., Strowig, T., Jin, C., Eisenbarth, S. C., & Flavell, R. A. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1016814108 · Cited by 452
“Support for the involvement of IL-18 came from a recent article in which IL-18 mice were shown to develop severe colitis and also increased tumorigenesis compared with WT, suggesting that enhanced tumorigenesis in TLR dysfunctional mice is linked to signaling through the IL-18 receptor (27).”
BackgroundHost–microbiota maladaptation in colorectal cancer
Janney, A., Powrie, F., & Mann, E. H. (2020) · Nature · doi:10.1038/s41586-020-2729-3 · Cited by 445
A functional role for NLRP6 in intestinal inflammation and tumorigenesis
Chen, G. Y., Liu, M., Wang, F., Bertin, J., & Núñez, G. (2011) · The Journal of Immunology · doi:10.4049/jimmunol.1100412 · Cited by 436
The role of the immune system in governing host-microbe interactions in the intestine
Brown, E. M., Sadarangani, M., & Finlay, B. B. (2013) · Nature Immunology · doi:10.1038/ni.2611 · Cited by 404
Chronic intestinal inflammation: inflammatory bowel disease and colitis-associated colon cancer
Rubin, D. C., Shaker, A., & Levin, M. S. (2012) · Frontiers in Immunology · doi:10.3389/fimmu.2012.00107 · Cited by 404
Epithelial Toll-like receptors and their role in gut homeostasis and disease
Burgueño, J. F., & Abreu, M. T. (2020) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/s41575-019-0261-4 · Cited by 395
Emerging cytokine networks in colorectal cancer
West, N. R., McCuaig, S., Franchini, F., & Powrie, F. (2015) · Nature Reviews Immunology · doi:10.1038/nri3896 · Cited by 396
Innate immune signaling and regulation in cancer immunotherapy
Corrales, L., Matson, V., Flood, B., Spranger, S., & Gajewski, T. F. (2017) · Cell Research · doi:10.1038/cr.2016.149 · Cited by 408
Innate immune mechanisms of colitis and colitis-associated colorectal cancer
Saleh, M., & Trinchieri, G. (2011) · Nature Reviews Immunology · doi:10.1038/nri2891 · Cited by 403
“This results in deficient repair of the intestinal barrier following radiation or chemical injury and enhanced susceptibility to colitis and colitis-associated colorectal cance”
BackgroundSelf-citationKarki, R., Man, S. M., & Kanneganti, T.-D. (2017) · Cancer Immunology Research · doi:10.1158/2326-6066.cir-16-0269 · Cited by 377
“In contrastwith previous studies showing thatmice lacking IL18 are susceptible to DSS-induced intestinal inflammation and tumorigenesis (9, 16, 17), a study has found that mice with a conditional deletion of IL18 in either epithelial cells or hematopoietic cells are more resistant to DSS-induced colitis compared with…”
NLRP6 Protects Il10 Mice from Colitis by Limiting Colonization of Akkermansia muciniphila
Seregin, S. S., Golovchenko, N., Schaf, B., Chen, J., Pudlo, N. A., Mitchell, J., Baxter, N. T., Zhao, L., Schloss, P. D., Martens, E. C., et al. (2017) · Cell Reports · doi:10.1016/j.celrep.2017.03.080 · Cited by 386
“IL-18 deficiency, in turn, has been suggested to impair epithelial restitution after DSS-induced injury, which is consistent with IL-18 being upstream of MyD88 signaling that is important for commensal-induced reparative immune responses (Rakoff-Nahoum et al., 2004; Salcedo et al., 2010).”
BackgroundNOD-Like Receptors: Versatile Cytosolic Sentinels
Motta, V., Soares, F., Sun, T., & Philpott, D. J. (2015) · Physiological Reviews · doi:10.1152/physrev.00009.2014 · Cited by 353
Gut microbiota-mediated inflammation in obesity: a link with gastrointestinal cancer
Cani, P. D., & Jordan, B. F. (2018) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/s41575-018-0025-6 · Cited by 383
The Multifaceted Role of the Intestinal Microbiota in Colon Cancer
Irrazábal, T., Belcheva, A., Girardin, S. E., Martin, A., & Philpott, D. J. (2014) · Molecular Cell · doi:10.1016/j.molcel.2014.03.039 · Cited by 344
“In contrast, MyD88 signaling is protective in carcinogen/dextran sodium sulfate (DSS) colitis-associated cancer (CAC) (Salcedo et al., 2010).”
BackgroundInfluentialThe Role of the Gut Microbiome in Colorectal Cancer Development and Therapy Response
Sánchez-Alcoholado, L., Ramos-Molina, B., Otero, A., Laborda-Illanes, A., Ordóñez, R., Medina, J. A., Gómez-Millán, J., & Queipo-Ortuño, M. I. (2020) · Cancers · doi:10.3390/cancers12061406 · Cited by 337
“Butyrate has been shown to be able to induce IL-18 production in intestinal epithelial cells by activating GPR109a receptor, which stimulates the mucosal tissue repair through the regulation of the production and availability of IL-22 [69].”
BackgroundThe Yin and Yang of Toll-like receptors in cancer
Pradere, J.-P., Dapito, D. H., & Schwabe, R. F. (2014) · Oncogene · doi:10.1038/onc.2013.302 · Cited by 331
Dupaul-Chicoine, J., Arabzadeh, A., Dagenais, M., Douglas, T., Champagne, C., Morizot, A., Rodrigue-Gervais, I. G., Breton, V., Colpitts, S. L., Beauchemin, N., et al. (2015) · Immunity · doi:10.1016/j.immuni.2015.08.013 · Cited by 342
“…Il-18 or Il-18r, exhibit increased colitis and tumorigenesis compared to wild-type (WT) mice in the azoxymethane-dextran sulfate sodium (AOM-DSS) model (Allen et al., 2010; Dupaul-Chicoine et al., 2010; Elinav et al., 2011; Huber et al., 2012; Salcedo et al., 2010; Zaki et al., 2010a, 2010b).”
BackgroundGastrointestinal Malignancy and the Microbiome
Abreu, M. T., & Peek, R. M. (2014) · Gastroenterology · doi:10.1053/j.gastro.2014.01.001 · Cited by 322
Mechanisms and pathways of innate immune activation and regulation in health and cancer
Cui, J., Chen, Y., Wang, H. Y., & Wang, R.-F. (2014) · Human Vaccines & Immunotherapeutics · doi:10.4161/21645515.2014.979640 · Cited by 309
“However, another study shows that loss of MyD88 increases tumor incidence in AOM-DSS-induced model, due to the reduced ability to heal ulcers and repair DNA damage.(207) This further reiterates the dual roles of TLR signaling in cancer.”
BackgroundInflammasomes in the gastrointestinal tract: infection, cancer and gut microbiota homeostasis
Man, S. M. (2018) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/s41575-018-0054-1 · Cited by 302
“Mice lacking IL-18 are highly susceptible to the development of colitis and CRC 183, 212, 213 .”
BackgroundNLRP1 Inflammasome Activation Induces Pyroptosis of Hematopoietic Progenitor Cells
Masters, S. L., Gerlic, M., Metcalf, D., Preston, S., Pellegrini, M., O’Donnell, J. A., McArthur, K., Baldwin, T. M., Chevrier, S., Nowell, C. J., et al. (2012) · Immunity · doi:10.1016/j.immuni.2012.08.027 · Cited by 313
“, 2001) but increases severity of DSS-induced colitis and enhances azoxymethane/DSS-induced adenocarcinoma formation (Salcedo et al., 2010; Zaki et al., 2010).”
Molecular mechanisms and functions of pyroptosis in inflammation and antitumor immunity
Hou, J., Hsu, J.-M., & Hung, M.-C. (2021) · Molecular Cell · doi:10.1016/j.molcel.2021.09.003 · Cited by 301
Inflammasome-independent role of AIM2 in suppressing colon tumorigenesis via DNA-PK and Akt
Wilson, J. E., Petrucelli, A. S., Chen, L., Koblansky, A. A., Truax, A. D., Oyama, Y., Rogers, A. B., Brickey, W. J., Wang, Y., Schneider, M., et al. (2015) · Nature Medicine · doi:10.1038/nm.3908 · Cited by 294
Focus on the Role of NLRP3 Inflammasome in Diseases
Fusco, R., Siracusa, R., Genovese, T., Cuzzocrea, S., & Di Paola, R. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21124223 · Cited by 290
Dzutsev, A., Badger, J. H., Perez-Chanona, E., Roy, S., Salcedo, R., Smith, C. K., & Trinchieri, G. (2017) · Annual Review of Immunology · doi:10.1146/annurev-immunol-051116-052133 · Cited by 302
“However, paradoxically, results in IL-18-deficient mice suggest that in the large intestine this cytokine has anti-inflammatory properties and mediates mucosal protective mechanisms (147).”
ResultSelf-citationInflammasomes in cancer: a double-edged sword
Kolb, R., Liu, G.-H., Janowski, A. M., Sutterwala, F. S., & Zhang, W. (2014) · Protein & Cell · doi:10.1007/s13238-013-0001-4 · Cited by 287
The Role of the Microbiota in Inflammation, Carcinogenesis, and Cancer Therapy
Dzutsev, A., Goldszmid, R. S., Viaud, S., Zitvogel, L., & Trinchieri, G. (2015) · European Journal of Immunology · doi:10.1002/eji.201444972 · Cited by 300
Self-citationThe NLRP3 inflammasome: Contributions to intestinal homeostasis
Zaki, M. H., Lamkanfi, M., & Kanneganti, T.-D. (2011) · Trends in Immunology · doi:10.1016/j.it.2011.02.002 · Cited by 290
NOD-Like Receptors: Master Regulators of Inflammation and Cancer
Saxena, M., & Yeretssian, G. (2014) · Frontiers in Immunology · doi:10.3389/fimmu.2014.00327 · Cited by 274
“Moreover, it has been shown that Il18−/− or Il18r−/− mice are more susceptible to DSS-induced colitis and CRC, mimicking the increased tumor burdens observed in NLRP3 and caspase-1 deficient mice (201).”
BackgroundSTAT3-Driven Upregulation of TLR2 Promotes Gastric Tumorigenesis Independent of Tumor Inflammation
Tye, H., Kennedy, C. L., Najdovska, M., McLeod, L., McCormack, W., Hughes, N., Dev, A., Sievert, W., Ooi, C. H., Ishikawa, T.-O., et al. (2012) · Cancer Cell · doi:10.1016/j.ccr.2012.08.010 · Cited by 273
Proteobacteria-specific IgA regulates maturation of the intestinal microbiota
Mirpuri, J., Raetz, M., Sturge, C. R., Wilhelm, C. L., Benson, A., Savani, R. C., Hooper, L. V., & Yarovinsky, F. (2014) · Gut Microbes · doi:10.4161/gmic.26489 · Cited by 280
Interplay between food and gut microbiota in health and disease
Danneskiold-Samsøe, N. B., Dias de Freitas Queiroz Barros, H., Santos, R., Bicas, J. L., Cazarin, C. B. B., Madsen, L., Kristiansen, K., Pastore, G. M., Brix, S., & Maróstica Júnior, M. R. (2019) · Food Research International · doi:10.1016/j.foodres.2018.07.043 · Cited by 268
“…with GPR109A, butyrate has been shown to mediate secretion of IL-18 via intestinal epithelial cells (Singh et al., 2014), which is reported to be involved in ACCEPTED MANUSCRIPT AC C EP TE D M AN U SC R IP T suppression of colonic inflammation (Elinav et al., 2011; Salcedo et al., 2010).”
BackgroundIntestinal antimicrobial peptides during homeostasis, infection, and disease
Muniz, L. R., Knosp, C., & Yeretssian, G. (2012) · Frontiers in Immunology · doi:10.3389/fimmu.2012.00310 · Cited by 252
“Recently, it was reported that deficiencies in the NLR/Caspase-1/IL-18 pathways are associated with a more severe phenotype in mouse models of acute dextran-sulfate sodium (DSS) colitis, possibly mediated, in part, by a defect in microbiota composition and in mucosal tissue repair (Allen et al., 2010, 2012b; Dupaul-Ch…”
BackgroundMicrobiome, inflammation and colorectal cancer
Chen, J., Pitmon, E., & Wang, K. (2017) · Seminars in Immunology · doi:10.1016/j.smim.2017.09.006 · Cited by 265
The role of pattern recognition receptors in intestinal inflammation
Fukata, M., & Arditi, M. (2013) · Mucosal Immunology · doi:10.1038/mi.2013.13 · Cited by 253
Bioactive Compounds Isolated from Microalgae in Chronic Inflammation and Cancer
Talero, E., García-Mauriño, S., Ávila-Román, J., Rodríguez-Luna, A., Alcaide, A., & Motilva, V. (2015) · Marine Drugs · doi:10.3390/md13106152 · Cited by 255
“In animals IL18−/− or deficient in its receptor, the combination of azoxymethane (AOM) and DSS showed a large number of tumors, and the authors suggested a role of NLRP3 in the supression of such tumors [101].”
BackgroundThe Necroptosis Adaptor RIPK3 Promotes Injury-Induced Cytokine Expression and Tissue Repair
Moriwaki, K., Balaji, S., McQuade, T., Malhotra, N., Kang, J., & Chan, F. K.-M. (2014) · Immunity · doi:10.1016/j.immuni.2014.09.016 · Cited by 254
“Il18 / , Myd88 / , Nlrp3 / , Asc / , and Casp1 / mice are highly sensitive to DSS-induced colitis (Allen et al., 2010; Dupaul-Chicoine et al., 2010; Elinav et al., 2011; Huber et al., 2012; Salcedo et al., 2010; Zaki et al., 2010).”
Non-redundant properties of IL-1α and IL-1β during acute colon inflammation in mice
Bersudsky, M., Luski, L., Fishman, D., White, R. M., Ziv-Sokolovskaya, N., Dotan, S., Rider, P., Kaplanov, I., Aychek, T., Dinarello, C. A., et al. (2014) · Gut · doi:10.1136/gutjnl-2012-303329 · Cited by 252
Inflammation and immune surveillance in cancer
Chow, M. T., Möller, A., & Smyth, M. J. (2012) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2011.12.004 · Cited by 241
Gut microbiota, host health, and polysaccharides
Xu, X., Xu, P., Ma, C., Tang, J., & Zhang, X. (2013) · Biotechnology Advances · doi:10.1016/j.biotechadv.2012.12.009 · Cited by 245
“IL-18 has been implicated in protecting against colorectal tumorigenesis (Salcedo et al., 2010; Zaki et al., 2010b).”
Aldara activates TLR7-independent immune defence
Walter, A., Schäfer, M., Cecconi, V., Matter, C., Urosevic-Maiwald, M., Belloni, B., Schönewolf, N., Dummer, R., Bloch, W., Werner, S., et al. (2013) · Nature Communications · doi:10.1038/ncomms2566 · Cited by 245
NLRP3 signaling drives macrophage-induced adaptive immune suppression in pancreatic carcinoma
Daley, D., Mani, V. R., Mohan, N., Akkad, N., Pandian, G. S. D. B., Savadkar, S., Lee, K. B., Torres-Hernandez, A., Aykut, B., Diskin, B., et al. (2017) · Journal of Experimental Medicine · doi:10.1084/jem.20161707 · Cited by 244
“In gastric carcinoma, deletion of IL-18, ASC, and caspase-1 have each been associated with accelerated tumorigenesis (Allen et al., 2010; Dupaul-Chicoine et al., 2010; Salcedo et al., 2010; Zaki et al., 2010).”
BackgroundWosen, J. E., Mukhopadhyay, D., Macaubas, C., & Mellins, E. D. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2018.02144 · Cited by 237
Yang, X. D., Ai, W., Asfaha, S., Bhagat, G., Friedman, R. A., Jin, G., Park, H., Shykind, B., Diacovo, T. G., Falus, A., et al. (2011) · Nature Medicine · doi:10.1038/nm.2278 · Cited by 233
The Spectrum of Achalasia: Lessons From Studies of Pathophysiology and High-Resolution Manometry
Kahrilas, P. J., & Boeckxstaens, G. (2013) · Gastroenterology · doi:10.1053/j.gastro.2013.08.038 · Cited by 235
Gut microbiota and probiotics in colon tumorigenesis
Zhu, Y., Michelle Luo, T., Jobin, C., & Young, H. A. (2011) · Cancer Letters · doi:10.1016/j.canlet.2011.06.004 · Cited by 229
Cytokine-Induced Modulation of Colorectal Cancer
Mager, L. F., Wasmer, M.-H., Rau, T. T., & Krebs, P. (2016) · Frontiers in Oncology · doi:10.3389/fonc.2016.00096 · Cited by 216
“Mice deficient in Il18 or Il18r1 developed more tumors upon AOM/DSS treatment, compared with WT controls (152).”
BackgroundThe role of gut microbiota in the pathogenesis of colorectal cancer
Zhu, Q., Gao, R., Wu, W., & Qin, H. (2013) · Tumor Biology · doi:10.1007/s13277-013-0684-4 · Cited by 209
“Moreover, the innate adapter protein, MyD88, can prevent the development of CAC by transmitting IL-18 receptor signaling [65].”
BackgroundMalik, A., Sharma, D., Malireddi, R. K. S., Guy, C. S., Chang, T.-C., Olsen, S. R., Neale, G., Vogel, P., & Kanneganti, T.-D. (2018) · Immunity · doi:10.1016/j.immuni.2018.08.024 · Cited by 196
“IL-18 is known to be a limiting factor in IFN-g production in the colon (Salcedo et al., 2010) and in line with our observations of defective IL-18 secretion in colons from Card9 / mice, they also have lower production of IFN-g from T cells during experimental colitis.”
Regulation of Mouse NK Cell Development and Function by Cytokines
Marçais, A., Viel, S., Grau, M., Henry, T., Marvel, J., & Walzer, T. (2013) · Frontiers in Immunology · doi:10.3389/fimmu.2013.00450 · Cited by 178
“In contrast, others studies have demonstrated an anti-tumor effect of IL-18 (172, 173) in part through the generation of “helper” NK cells producing CCL3 and CCL4, which results to the local recruitment of DCs and effector CD8 T cells (174).”
ResultScheibe, K., Backert, I., Wirtz, S., Hueber, A., Schett, G., Vieth, M., Probst, H. C., Bopp, T., Neurath, M. F., & Neufert, C. (2017) · Gut · doi:10.1136/gutjnl-2015-310374 · Cited by 188
The cross talk between microbiota and the immune system: metabolites take center stage
Shapiro, H., Thaiss, C. A., Levy, M., & Elinav, E. (2014) · Current Opinion in Immunology · doi:10.1016/j.coi.2014.07.003 · Cited by 189
“On the other hand, deficiency in GPR109A reduces the colonic epithelial secretion of IL-18, a cytokine that function as a major regulator of microbiota ecology and colonic homeostasis [10–13].”
BackgroundCytokine-Mediated Crosstalk between Immune Cells and Epithelial Cells in the Gut
Mahapatro, M., Erkert, L., & Becker, C. (2021) · Cells · doi:10.3390/cells10010111 · Cited by 177
The interplay between autophagy and ROS in tumorigenesis
Kongara, S., & Karantza, V. (2012) · Frontiers in Oncology · doi:10.3389/fonc.2012.00171 · Cited by 184
Context-dependent role of IL-18 in cancer biology and counter-regulation by IL-18BP
Fabbi, M., Carbotti, G., & Ferrini, S. (2015) · Journal of Leukocyte Biology · doi:10.1189/jlb.5ru0714-360rr · Cited by 177
Interleukin-10 Ablation Promotes Tumor Development, Growth, and Metastasis
Tanikawa, T., Wilke, C. M., Kryczek, I., Chen, G. Y., Kao, J., Núñez, G., & Zou, W. (2012) · Cancer Research · doi:10.1158/0008-5472.can-10-4627 · Cited by 174
“In addition to immunosuppressive effects, IL-10 also exerts some immunostimulatory effects, such as promoting the generation of cytotoxic T lymphocytes, activating B cells (1, 3, 12), and upregulating a small number of genes in TLR-activated macrophages and DCs (13).”
Gut Microbiota in Colorectal Cancer: Biological Role and Therapeutic Opportunities
Pandey, H., Tang, D. W. T., Wong, S. H., & Lal, D. (2023) · Cancers · doi:10.3390/cancers15030866 · Cited by 159
Goldszmid, R. S., & Trinchieri, G. (2012) · Nature Immunology · doi:10.1038/ni.2422 · Cited by 166
Self-citationPattern recognition receptors—Molecular orchestrators of inflammation in inflammatory bowel disease
Walsh, D., McCarthy, J., O’Driscoll, C., & Melgar, S. (2013) · Cytokine & Growth Factor Reviews · doi:10.1016/j.cytogfr.2012.09.003 · Cited by 160
Host Immune Response to Infection and Cancer: Unexpected Commonalities
Goldszmid, R. S., Dzutsev, A., & Trinchieri, G. (2014) · Cell Host & Microbe · doi:10.1016/j.chom.2014.02.003 · Cited by 165
“Mice unable to produce, process, or respond to IL-18 display dysbiosis and have an increased susceptibility to chemical colon and liver carcinogenesis that can be transferred to WT mice by cohousing (Elinav et al., 2013; Salcedo et al., 2010).”
Self-citationThe Fire Within: Microbes Inflame Tumors
Gagliani, N., Hu, B., Huber, S., Elinav, E., & Flavell, R. A. (2014) · Cell · doi:10.1016/j.cell.2014.03.006 · Cited by 165
“Likewise, Il18- and Il18r-deficient mice were shown to be hypersusceptible to DSS-induced colitis and colorectal tumorigenesis (Salcedo et al., 2010).”
BackgroundTumor-Elicited Inflammation and Colorectal Cancer
(2015) · Advances in Cancer Research · doi:10.1016/bs.acr.2015.04.014 · Cited by 161
STING-Dependent Signaling Underlies IL-10 Controlled Inflammatory Colitis
Ahn, J., Son, S., Oliveira, S. C., & Barber, G. N. (2017) · Cell Reports · doi:10.1016/j.celrep.2017.11.101 · Cited by 165
Pyrin Inflammasome Regulates Tight Junction Integrity to Restrict Colitis and Tumorigenesis
Sharma, D., Malik, A., Guy, C. S., Karki, R., Vogel, P., & Kanneganti, T.-D. (2018) · Gastroenterology · doi:10.1053/j.gastro.2017.11.276 · Cited by 162
Kanai, T., Mikami, Y., & Hayashi, A. (2015) · Journal of Gastroenterology · doi:10.1007/s00535-015-1084-x · Cited by 159
“In addition, AOM/DSS Il18 and Il18r1 mice are more susceptible to colitis and polyp formation than wild-type mice are [41].”
BackgroundThe NLRP1 inflammasome attenuates colitis and colitis-associated tumorigenesis
Williams, T. M., Leeth, R. A., Rothschild, D. E., Coutermarsh-Ott, S. L., McDaniel, D. K., Simmons, A. E., Heid, B., Cecere, T. E., & Allen, I. C. (2015) · The Journal of Immunology · doi:10.4049/jimmunol.1402098 · Cited by 162
Experimental Inflammatory Bowel Disease: Insights into the Host-Microbiota Dialog
Saleh, M., & Elson, C. O. (2011) · Immunity · doi:10.1016/j.immuni.2011.03.008 · Cited by 157
Inflammasomes in Intestinal Inflammation and Cancer
Chen, G. Y., & Núñez, G. (2011) · Gastroenterology · doi:10.1053/j.gastro.2011.10.002 · Cited by 150
NF-κB: a double-edged sword controlling inflammation
Liu, D., Zhong, Z., & Karin, M. (2022) · Biomedicines · doi:10.3390/biomedicines10061250 · Cited by 157
Wong, J. L., Berk, E., Edwards, R. P., & Kaliński, P. (2013) · Cancer Research · doi:10.1158/0008-5472.can-12-4366 · Cited by 163
“Although IL-18 has been reported to favor protective antitumor immunity (40, 41), IL-18 has also been recently implicated in tumor-associated immunosuppression through its promotion of a Kitþ subset of regulatory NK cells overexpressing PD-L1 (42, 43).”
BackgroundLiu, Z., Brooks, R. S., Ciappio, E. D., Kim, S. J., Crott, J. W., Bennett, G., Greenberg, A. S., & Mason, J. B. (2012) · The Journal of Nutritional Biochemistry · doi:10.1016/j.jnutbio.2011.07.002 · Cited by 150
The Gastrointestinal Tumor Microenvironment
Quante, M., Varga, J., Wang, T. C., & Greten, F. R. (2013) · Gastroenterology · doi:10.1053/j.gastro.2013.03.052 · Cited by 151
Boleij, A., & Tjalsma, H. (2012) · Biological Reviews · doi:10.1111/j.1469-185x.2012.00218.x · Cited by 146
Metadata
- Authors
- Salcedo, R., Worschech, A., Cardone, M., Jones, Y., Gyulai, Z., Dai, R.-M., Wang, E., Ma, W., Haines, D., O'hUigin, C., Marincola, F. M., & Trinchieri, G.
- Affiliations
- National Cancer Institute (US)
- National Institutes of Health (US)
- Cancer and Inflammation Program, Center for Cancer Research, National Cancer Institute, Frederick, MD 21701 1
- Science Applications International Corporation (United States) (US)
- Corresponding author
- Trinchieri, Giorgio
- Venue
- Journal of Experimental Medicine
- Publisher
- Rockefeller University Press
- Published
- 2010-07-12
- Volume
- 207
- Issue
- 8
- Pages
- 1625-1636
- ISSN
- 0022-1007 (ISSN-L)
- 1540-9538
- PMC
- PMC2916129
- OpenAlex
- W2118983602
- Cited by
- 429
- References
- 44
- Citations by year
- 2026: 8 · 2025: 12 · 2024: 10 · 2023: 24 · 2022: 21 · 2021: 24 · 2020: 26 · 2019: 21 · 2018: 38 · 2017: 38 · 2016: 18 · 2015: 35 · 2014: 36 · 2013: 42 · 2012: 37
- FWCI
- 16.09
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Licence
- cc-by-nc-sa
- Locations
- The Journal of Experimental Medicine (publishedVersion)
- PubMed Central (publishedVersion, cc-by-nc-sa)
- PubMed (publishedVersion)
- Funders
- National Institutes of Health (HHSN261200800001C)
- National Cancer Institute (HHSN261200800001E))
- Topics
- Life Sciences › Immunology and Microbiology › Immunology › Immune Response and Inflammation
- Health Sciences › Medicine › Gastroenterology › Inflammatory Bowel Disease
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › NF-κB Signaling Pathways
- Keywords
- MyD88 signaling, IL-18, interleukin-18 receptor, colitis-associated colorectal cancer, colon adenocarcinoma, carcinogenesis, inflammatory bowel disease, CTNNB1 mutation, adenoma formation, MyD88-deficient mice, TLR2, TLR4, tissue homeostasis
- MeSH terms
- Adenocarcinoma, Animals, Azoxymethane, Colon, Colonic Neoplasms, Colonic Polyps, Epithelial Cells, Intestinal Mucosa, Mice, Inbred C57BL, Mutation, Phosphorylation, Specific Pathogen-Free Organisms, Inflammatory Bowel Diseases, Signal Transduction, Gene Expression, Dextran Sulfate, Apoptosis, Mice, Knockout, Genetic Predisposition to Disease, Interleukin-18, Gene Expression Profiling, DNA Repair Enzymes, Cell Proliferation, STAT3 Transcription Factor, beta Catenin, Mice, Cyclooxygenase 2, Receptors, Interleukin-1 Type I, Myeloid Differentiation Factor 88, Interleukin-18 Receptor alpha Subunit
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.